October 1, 2018 / 6:28 AM / 16 days ago

Denmark's Abacus Medicine says it plans IPO in Frankfurt

COPENHAGEN (Reuters) - Denmark-based pharmaceutical parallel trade company Abacus Medicine is preparing a listing on the Frankfurt Stock Exchange, it said on Monday.

The initial public offering (IPO) is expected to consist of newly issued shares from a capital increase with targeted proceeds of approximately 40 million euros ($46.36 million) and the sale of existing shares from existing shareholders.

Reporting by Teis Jensen, editing by Louise Heavens

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below